We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+7.8%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$484B
AUM Growth
+$29.1B
Cap. Flow
-$16.6B
Cap. Flow %
-3.43%
Top 10 Hldgs %
36.47%
Holding
15,826
New
1,205
Increased
5,575
Reduced
7,223
Closed
1,562

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$545M
2
DXCM icon
DexCom
DXCM
+$457M
3
T icon
AT&T
T
+$431M
4
PANW icon
Palo Alto Networks
PANW
+$416M
5
HUM icon
Humana
HUM
+$394M

Sector Composition

Rank Sector Weight
1 Technology 3.03%
2 Healthcare 2.92%
3 Consumer Discretionary 1.99%
4 Financials 1.93%
5 Industrials 1.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OMGA
12751
CALL
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$17.9K ﹤0.01%
3,200
-4,600
-59% -$36K
BVS icon
12752
PUT
Bioventus
BVS
$1.2B
$17.9K ﹤0.01%
+6,200
New +$11.9K
BTMDW
12753
DELISTED
Biote Corp. Warrant
BTMDW
$17.9K ﹤0.01%
11,108
+8
+0.1% +$8
SMC
12754
CALL
Summit Midstream
SMC
$482M
$17.9K ﹤0.01%
1,100
-2,900
-73% -$44.6K
OFS icon
12755
PUT
OFS Capital
OFS
$48.1M
$17.8K ﹤0.01%
1,800
-1,200
-40% -$11.8K
PHX
12756
PUT
DELISTED
PHX Minerals
PHX
$17.8K ﹤0.01%
5,700
+700
+14% +$1.99K
GROW icon
12757
CALL
US Global Investors
GROW
$39.4M
$17.7K ﹤0.01%
5,800
-1,700
-23% -$4.72K
WEL.WS
12758
DELISTED
Integrated Wellness Acquisition Corp Redeemable Warrants
WEL.WS
$17.7K ﹤0.01%
+21,122
New +$17.4K
ANGO icon
12759
CALL
AngioDynamics
ANGO
$655M
$17.7K ﹤0.01%
1,700
-4,300
-72% -$41.4K
DNLI icon
12760
PUT
Denali Therapeutics
DNLI
$3.9B
$17.7K ﹤0.01%
600
-11,400
-95% -$321K
NL icon
12761
CALL
NLI Holdings
NL
$315M
$17.7K ﹤0.01%
3,200
-4,400
-58% -$26.2K
CELC icon
12762
PUT
Celcuity
CELC
$4.5B
$17.6K ﹤0.01%
1,600
+1,100
+220% +$11.4K
IGMS
12763
PUT
DELISTED
IGM Biosciences
IGMS
$17.5K ﹤0.01%
1,900
-4,100
-68% -$45.9K
GRPN icon
12764
Groupon
GRPN
$875M
$17.5K ﹤0.01%
+2,966
New +$13.1K
ARQ icon
12765
CALL
Arq
ARQ
$102M
$17.5K ﹤0.01%
9,400
+9,300
+9,300% +$15.4K
ASMB icon
12766
CALL
Assembly Biosciences
ASMB
$671M
$17.5K ﹤0.01%
1,267
-991
-44% -$12.2K
PFFD icon
12767
PUT
Global X US Preferred ETF
PFFD
$2.17B
$17.5K ﹤0.01%
900
-12,700
-93% -$246K
CMND icon
12768
Clearmind Medicine
CMND
$2.76M
$17.4K ﹤0.01%
3
+2
+200% +$13.5K
LYT
12769
DELISTED
Lytus Technologies Holdings PTV. Ltd. Common Shares
LYT
$17.4K ﹤0.01%
645
+365
+130% +$13.3K
EWH icon
12770
PUT
iShares MSCI Hong Kong ETF
EWH
$1.21B
$17.4K ﹤0.01%
900
-18,900
-95% -$380K
MIST icon
12771
PUT
Milestone Pharmaceuticals
MIST
$137M
$17.4K ﹤0.01%
6,100
-71,400
-92% -$269K
VIVK
12772
Vivakor
VIVK
$893K
$17.3K ﹤0.01%
+4
New +$18.2K
TBRG
12773
PUT
DELISTED
TruBridge
TBRG
$17.3K ﹤0.01%
700
+600
+600% +$15.6K
CFFN icon
12774
PUT
Capitol Federal Financial
CFFN
$1.08B
$17.3K ﹤0.01%
2,800
+600
+27% +$3.73K
AKR icon
12775
PUT
Acadia Realty Trust
AKR
$2.86B
$17.3K ﹤0.01%
1,200
+800
+200% +$10.8K

Similar funds

Ken Griffin's Q2 2023 Portfolio in Review

As of Q2 2023, Ken Griffin held 15,826 positions worth $484B, up 6.4% from $455B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Ken Griffin withdrew a net $16.6B in Q2 2023, closing 1,562 positions and reducing 7,223 holdings. Its most notable exit was State Street Industrial Select Sector SPDR ETF, an estimated $192M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Ken Griffin opened a new position in BILL Holdings worth $222M.

  • Ken Griffin's largest Q2 2023 buy was BILL Holdings: 1,901,064 shares worth $222M.
  • Ken Griffin added most to Microsoft in Q2 2023, an estimated $640M increase.
  • Ken Griffin's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $545M.
  • Ken Griffin fully exited State Street Industrial Select Sector SPDR ETF in Q2 2023, selling an estimated $192M.
  • Ken Griffin's ten largest holdings make up 36% of its $484B portfolio in Q2 2023.
  • Ken Griffin opened 1,205 new positions and closed 1,562 in Q2 2023.
  • Ken Griffin's portfolio value rose 6.4% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.